Skip to main content

Duration of Follow Up for New Molecular Entities Approved in 2022: First Descriptive Analysis

    Basic Details
    Date Posted
    Status
    Complete
    Medical Product
    new molecular entities (NMEs)
    Description

    In this report, we characterized dispensing and administration patterns of 37 New Molecular Entities (NMEs) approved from January 1, 2022 through December 31, 2022, stratified by age and sex in the Sentinel Distributed Database (SDD).

    The study period includes data from January 1, 2022 to November 14, 2024 . We distributed this request to five Sentinel Data Partners on November 14, 2024.

    Additional Details
    FDA Center
    CDER
    Time Period
    January 1, 2022 - May 31, 2024
    Analysis Type
    Descriptive
    Population / Cohort
    All individuals
    Data Sources
    Sentinel Distributed Database (SDD)